Miguel Hernandez Pampaloni, MD, PhD

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Miguel Hernandez Pampaloni, MD, PhD

Associate Professor, Nuclear Medicine Chief, Dept of Radiology, UCSF

Phone: (415) 353-2573

UCSF Profiles | Physician Referral Directory | Dept of Radiology Profile

Cancer Center Membership

Program Member » Developmental Therapeutics

Research Summary

Miguel Hernandez Pampaloni, MD, PhD, is an Associate Professor in Residence and Chief of Nuclear Medicine in the Department of Radiology and Biomedical Imaging at the University of California, San Francisco. Dr. Pampaloni is responsible for all clinical administrative coordination, performance and supervision within the section. Dr. Pampaloni earned his PhD in Radiological Sciences from the Universidad Complutense School of Medicine in Madrid, Spain, and he obtained his MD from the Universidad Complutense School of Medicine. Dr. Pampaloni completed a residency in Nuclear Medicine at the San Carlos Hospital in Madrid, Spain, and he completed a residency in Nuclear Medicine at the University of Pennsylvania School of Medicine. Dr. Pampaloni was a postdoctoral fellow in Cardiovascular Nuclear Medicine at the David Geffen School of Medicine at UCLA, and he was a clinical research fellow in PET Cardiology at the Imperial College in London, England. Dr. Pampaloni joined the UCSF Nuclear Medicine Section as an Assistant Professor in 2009.

Dr. Pampaloni has two main research interests: applications of molecular imaging into the cardiovascular field and oncology. He is interested in assessing the pathophysiological changes in the inflammatory process at the base of the coronary artery disease by non-invasive evaluation of endothelial function with positron emission tomography. He is particularly interested in developing a molecular imaging model to assess quantitatively the initial changes in the atherosclerotic process, which may help for an early, preclinical, diagnosis. As part of vascular biology characteristics, he is interested in applying new developed radioligands to target specific processes in the angiogenesis of cancer.

Dr. Pampaloni has written over 40 articles, 6 book chapters, 75 abstracts, and 5 significant publications where he is author and co-author.

Education

Liceo Scientifico Italiano "Enrico Fermi"
Universidad Complutense, Madrid, MD 1990
Universidad Complutense, Madrid, PhD 1998


Professional Experience

  • 2008-2009
    Postdoctoral Fellow, Dept of Radiology, University of Pennsylvania Hospital
  • 2009-present
    Assistant Professor, Dept of Radiology, UCSF
  • 2010-present
    Chief, Nuclear Medicine, Dept of Radiology, UCSF

Honors & Awards

  • 2002
    Society of Nuclear Medicine Meeting, Cardiovascular Young Investigator Award
  • 1999
    Spanish Society of Cardiology Annual Meeting, Best Communication Award

Selected Publications

  1. Hernandez Pampaloni M, Facchetti L, Nardo L. Pitfalls in [18F]FDG PET imaging in gynecological malignancies. Q J Nucl Med Mol Imaging. 2016 Jun; 60(2):124-38.
    View on PubMed
  2. Pampaloni MH, Nazer B, Botvinick E. Erratum to: Isolated right ventricular cardiac sarcoidosis demonstrated by (18)FDG positron emission tomography. J Nucl Cardiol. 2015 Feb; 22(1):221.
    View on PubMed
  3. Pampaloni MH, Nardo L. PET/MRI radiotracer beyond ¹8F-FDG. PET Clin. 2014 Jul; 9(3):345-9.
    View on PubMed
  4. Hernandez Pampaloni M, Nazer B, Nazar B, Botvinick E. Isolated right ventricular cardiac sarcoidosis demonstrated by ¹8FDG positron emission tomography. J Nucl Cardiol. 2014 Jun; 21(3):652-4.
    View on PubMed
  5. Ibrahim SF, Ahronowitz I, McCalmont TH, Hernandez Pampaloni M, Ryan JL, Yu SS. 18F-fluorodeoxyglucose positron emission tomography-computed tomography imaging in the management of Merkel cell carcinoma: a single-institution retrospective study. Dermatol Surg. 2013 Sep; 39(9):1323-33.
    View on PubMed

Go to UCSF Profiles, powered by CTSI